Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GR, Ingelmo M; Euro-Phospholipid Project Group..

Arthritis Rheum. 2002 Apr;46(4):1019-27.

PMID:
11953980
2.

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.

Cervera R, Boffa MC, Khamashta MA, Hughes GR.

Lupus. 2009 Sep;18(10):889-93. doi: 10.1177/0961203309106832.

PMID:
19671788
3.

Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?

Gómez-Puerta JA, Martín H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA.

Medicine (Baltimore). 2005 Jul;84(4):225-30.

4.

Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yagüe J, Cervera R, Ingelmo M, Font J.

Lupus. 2004;13(10):777-83.

PMID:
15540510
5.

[Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].

Chwalińska-Sadowska H, Meissner M, Wudarski M, Zabek J, Wojciechowska B.

Pol Arch Med Wewn. 2006 May;115(5):401-6. Polish.

PMID:
17195351
6.

Antiphospholipid syndrome and recurrent thrombosis in children.

Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G.

Arthritis Rheum. 2006 Dec 15;55(6):850-5.

7.

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.

Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.

Arthritis Rheum. 2004 Aug;50(8):2569-79.

8.

Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.

Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.

Haematologica. 2000 Jun;85(6):632-7.

9.

Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis.

Krause I, Leibovici L, Blank M, Shoenfeld Y.

Lupus. 2007;16(3):176-80.

PMID:
17432102
10.

Outcome of primary antiphospholipid syndrome in childhood.

Gattorno M, Falcini F, Ravelli A, Zulian F, Buoncompagni A, Martini G, Resti M, Picco P, Martini A.

Lupus. 2003;12(6):449-53.

PMID:
12873046
11.

Features associated with epilepsy in the antiphospholipid syndrome.

Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Khamashta MA, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jönsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Chapman J, van-Breda-Vriezman PJ, Damoiseaux J.

J Rheumatol. 2004 Jul;31(7):1344-8.

PMID:
15229954
12.

[Antiphospholipid syndrome in patients with systemic connective tissue diseases].

Unikiene D, Misiūniene N.

Medicina (Kaunas). 2003;39(5):454-9. Lithuanian.

13.

Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center.

Font J, Cervera R, Ramos-Casals M, García-Carrasco M, Sents J, Herrero C, del Olmo JA, Darnell A, Ingelmo M.

Semin Arthritis Rheum. 2004 Feb;33(4):217-30.

PMID:
14978660
14.

Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.

Avcin T, Cimaz R, Silverman ED, Cervera R, Gattorno M, Garay S, Berkun Y, Sztajnbok FR, Silva CA, Campos LM, Saad-Magalhaes C, Rigante D, Ravelli A, Martini A, Rozman B, Meroni PL.

Pediatrics. 2008 Nov;122(5):e1100-7. doi: 10.1542/peds.2008-1209.

PMID:
18955411
15.

[Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].

Reshetniak TM, Seredavkina nV, Mach ES, Aleksandrova EN, Novikov AA, Cherkasova MV, Nasonov EL.

Ter Arkh. 2008;80(10):60-7. Russian.

PMID:
19105418
16.

Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.

García-Carrasco M, Galarza C, Gómez-Ponce M, Cervera R, Rojas-Rodríguez J, Espinosa G, Bucciarelli S, Gómez-Puerta JA, Bové A, Escárcega RO, Font J.

Lupus. 2007;16(5):366-73.

PMID:
17576741
17.

Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.

Francès C, Niang S, Laffitte E, Pelletier Fl, Costedoat N, Piette JC.

Arthritis Rheum. 2005 Jun;52(6):1785-93.

18.
19.

Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.

Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.

J Rheumatol. 2006 Oct;33(10):1980-6.

PMID:
17014014
20.
Items per page

Supplemental Content

Support Center